4.6 Article

Diabetic Severity and Risk of Kidney Stone Disease

期刊

EUROPEAN UROLOGY
卷 65, 期 1, 页码 242-247

出版社

ELSEVIER
DOI: 10.1016/j.eururo.2013.03.026

关键词

Diabetes mellitus; Glycemic control; Insulin resistance; Kidney stone disease

资金

  1. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK089086]
  2. [K24 DK085446]
  3. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK089086, T32DK007357, K24DK085446] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: The prevalence of kidney stone disease is rising along with increasing rates of obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. Objective: To investigate the associations among the presence and severity of T2DM, glycemic control, and insulin resistance with kidney stone disease. Design, setting, and participants: We performed a cross-sectional analysis of all adult participants in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). A history of kidney stone disease was obtained by self-report. T2DM was defined by self-reported history, T2DM-related medication usage, and reported diabetic comorbidity. Insulin resistance was estimated using fasting plasma insulin (FPI) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) definition. We classified glycemic control using glycosylated hemoglobin A(1)c (HbA(1)c) and fasting plasma-glucose levels (FPG). Outcome measurements and statistical analysis: Odds ratios (OR) for having kidney stone disease were calculated for each individual measure of T2DM severity. Logistic regression models were fitted adjusting for age, sex, race/ethnicity, smoking history, and the Quetelet index (body mass index), as well as laboratory values and components of metabolic syndrome. Results and limitations: Correlates of kidney stone disease included a self-reported history of T2DM (OR: 2.44; 95% confidence interval [CI], 1.84-3.25) and history of insulin use (OR: 3.31; 95% CI, 2.02-5.45). Persons with FPG levels 100-126 mg/dl and >126 mg/dl had increased odds of having kidney stone disease (OR 1.28; 95% CI, 0.95-1.72; and OR 2.29; 95% CI, 1.68-3.12, respectively). Corresponding results for persons with HbA(1)c 5.7-6.4% and >= 6.5% were OR 1.68 (95% CI, 1.17-2.42) and OR 2.82 (95% CI, 1.98-4.02), respectively. When adjusting for patient factors, a history of T2DM, the use of insulin, FPI, and HbA(1)c remained significantly associated with kidney stone disease. The cross-sectional design limits causal inference. Conclusions: Among persons with T2DM, more-severe disease is associated with a heightened risk of kidney stones. (C) 2013 European Association of Urology. Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction

Alejandro Y. Meraz-Munoz, Nivethika Jeyakumar, Bin Luo, William Beaubien-Souligny, Rahul Chanchlani, Edward G. Clark, Ziv Harel, Abhijat Kitchlu, Javier A. Neyra, Michael Zappitelli, Glenn M. Chertow, Amit X. Garg, Ron Wald, Samuel A. Silver

Summary: Patients with a history of MI who survived AKI were less likely to receive prescriptions for cardiovascular drugs within 1 year of hospital discharge. This association was most pronounced in patients with stages 2 and 3 AKI.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Oncology

Groundwater constituents and the incidence of kidney cancer

Simon John Christoph Soerensen, Maria E. Montez-Rath, Iona Cheng, Scarlett Lin Gomez, Debora L. Oh, Christian Jackson, Jinhui Li, David Rehkopf, Glenn M. Chertow, Marvin E. Langston, Calyani Ganesan, Alan C. Pao, Benjamin I. Chung, John T. Leppert

Summary: This study evaluated the association between groundwater exposures and kidney cancer incidence and identified several groundwater constituents associated with kidney cancer. Public health efforts to reduce the burden of kidney cancer should consider groundwater constituents as environmental exposures that may be associated with the incidence of kidney cancer.

CANCER (2023)

Article Urology & Nephrology

Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis A Pilot Study

Shuchi Anand, Maria Montez-Rath, Meri Varkila, Xue Yu, Martha Block, Stephanie Brillhart, Amanda Leppink, Patti Hunsader, Douglas K. Owens, Glenn M. Chertow, Julie Parsonnet, Geoffrey A. Block

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Kidney Stone Events after Kidney Transplant in the United States

Calyani Ganesan, Malorie Holmes, Sai Liu, Maria Montez-Rath, Simon Conti, Timothy C. C. Chang, Colin R. Lenihan, Xingxing S. S. Cheng, Glenn M. Chertow, John T. Leppert, Alan C. C. Pao

Summary: Background: Kidney stone disease is common and can lead to complications in kidney transplant recipients. This study found that approximately 2% of kidney transplant recipients were diagnosed with a kidney stone in the first 3 years after transplantation. Risk factors for kidney stone events included a history of kidney stones and longer dialysis vintage.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Cardiac & Cardiovascular Systems

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

Glenn M. Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John J. V. McMurray, Peter Rossing, Anna Maria Langkilde, C. David Sjostrom, Robert D. Toto, David C. Wheeler, Hiddo J. L. Heerspink

Summary: In the DAPA-CKD trial, dapagliflozin was found to reduce the risk of kidney and cardiovascular events in patients with chronic kidney disease and albuminuria. The treatment effect of dapagliflozin was consistent regardless of baseline cardiovascular medication use.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Review Physiology

The potential roles of galectin-3 in AKI and CKD

Fengyun Wang, Lixin Zhou, Amity Eliaz, Chang Hu, Xinhua Qiang, Li Ke, Glenn Chertow, Isaac Eliaz, Zhiyong Peng

Summary: Acute kidney injury (AKI) and chronic kidney disease (CKD) are associated with high morbidity and mortality. Galectin-3 (Gal3), a protein with proinflammatory and profibrotic properties, has been implicated in the development and progression of both AKI and CKD. Elevated Gal3 levels in the serum of AKI and CKD patients and its association with CKD progression have been observed. Gal3 is also associated with AKI incidence in critically ill patients, and blocking Gal3 has shown promising results in reducing AKI incidence and mortality in animal models.

FRONTIERS IN PHYSIOLOGY (2023)

Letter Medicine, General & Internal

Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial

Priya Vart, Niels Jongs, David C. Wheeler, Hiddo J. L. Heerspink, Anna Maria Langkilde, Glenn M. Chertow

JAMA NETWORK OPEN (2023)

Article Cardiac & Cardiovascular Systems

Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention

Anezi Uzendu, Kevin Kennedy, Glenn Chertow, Amit P. Amin, Jay S. Giri, Jennifer A. Rymer, Sripal Bangalore, Kimberly Lavin, Cornelia Anderson, John A. Spertus

Summary: This study aimed to compare the accuracy and implications of different GFR equations in predicting AKI after PCI. The results showed that for Black patients, risk models without a race term were more accurate than models with a race term. This has important implications for reducing disparities and benchmarking.

JACC-CARDIOVASCULAR INTERVENTIONS (2023)

Letter Medicine, General & Internal

Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease

Vikram Fielding-Singh, Matthew W. Vanneman, Arden M. Morris, Glenn M. Chertow, Eugene Lin

Summary: This cohort study examines the relationship between patient characteristics and the time interval between hemodialysis and surgery in end-stage kidney disease patients.

JAMA NETWORK OPEN (2023)

Article Medicine, General & Internal

Use of Wastewater Metrics to Track COVID-19 in the US

Meri R. J. Varkila, Maria E. Montez-Rath, Joshua A. Salomon, Xue Yu, Geoffrey A. Block, Douglas K. Owens, Glenn M. Chertow, Julie Parsonnet, Shuchi Anand

Summary: The widespread use of at-home COVID-19 tests affects the determination of community COVID-19 incidence. A study found that wastewater metrics were associated with high case and hospitalization rates in the first quarter of 2022, but the association weakened in subsequent quarters, possibly due to underreporting, reduced testing, and the effect of vaccines and treatments. This study suggests using wastewater metrics to improve the assessment of community infection prevalence when conventional surveillance data is unreliable.

JAMA NETWORK OPEN (2023)

Meeting Abstract Transplantation

REASONS FOR DIALYSIS INITIATION AND SAFETY OF DAPAGLIFLOZIN AMONG DIALYSIS PARTICIPANTS: NEW INSIGHTS FROMDAPA-CKD

Hiddo Lambers Heerspink, David C. Wheeler, Niels Jong, Ricardo Correa-Rotter, Peter Rossing, Ronald Gansevoort, John Mcmurray, Anna Maria Langkilde, Robert Toto, Glenn Chertow

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Transplantation

APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE

Bertrand Knebelmann, Kate Bramham, Kieran Mccafferty, Mohamad Zaidan, Pablo Antonio Urena Torres, Vincent Audard, Jean Jacques Boffa, Thomas Powell, Nauman Shahid, Diego Echeverri, Christopher Provenzano, John Bauman, Aurelia Zamauskaite, Irisz Delestre-Levai, Yuan Yang, Silva Krause, Anna Carolina Ferreira, Ogo Egbuna, Glenn Chertow

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Transplantation

EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH CKD ACROSS THE SPECTRUM OF AGE AND BY SEX

Margaret Yu, Priya Vart, Hiddo Lambers Heerspink, Niels Jong, Ricardo Correa-Rotter, John Mcmurray, Peter Rossing, Anna Maria Langkilde, Robert Toto, David C. Wheeler, Glenn Chertow

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Transplantation

AMBIENT HEAT EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE TRAJECTORY: A POST-HOC ANALYSIS OF THE DAPA-CKD TRIAL

Zhiyan Zhang, Hiddo Lambers Ileerspink, Glenn Chertow, Ricardo Correa-Rotter, Antonio Gasparrini, Niels Jong, Anna Maria Langkilde, Malcolm Mistry, John Mcmurray, Peter Rossing, Robert Toto, Priya Vart, Dorothea Misch, David C. Wheeler, Ben Caplin

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Medicine, Research & Experimental

Class I and II Human Leukocyte Antigen Serotypes Associated with End-Stage Kidney Disease due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease

Halimat Afolabi, Bing Zhang, Michelle O'Shaughnessy, Glenn Chertow, Richard Lafayette, Vivek Charu

LABORATORY INVESTIGATION (2023)

暂无数据